BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

526 related articles for article (PubMed ID: 18842065)

  • 1. SLC2A9 is a high-capacity urate transporter in humans.
    Caulfield MJ; Munroe PB; O'Neill D; Witkowska K; Charchar FJ; Doblado M; Evans S; Eyheramendy S; Onipinla A; Howard P; Shaw-Hawkins S; Dobson RJ; Wallace C; Newhouse SJ; Brown M; Connell JM; Dominiczak A; Farrall M; Lathrop GM; Samani NJ; Kumari M; Marmot M; Brunner E; Chambers J; Elliott P; Kooner J; Laan M; Org E; Veldre G; Viigimaa M; Cappuccio FP; Ji C; Iacone R; Strazzullo P; Moley KH; Cheeseman C
    PLoS Med; 2008 Oct; 5(10):e197. PubMed ID: 18842065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mouse GLUT9: evidences for a urate uniporter.
    Bibert S; Hess SK; Firsov D; Thorens B; Geering K; Horisberger JD; Bonny O
    Am J Physiol Renal Physiol; 2009 Sep; 297(3):F612-9. PubMed ID: 19587147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human SLC2A9a and SLC2A9b isoforms mediate electrogenic transport of urate with different characteristics in the presence of hexoses.
    Witkowska K; Smith KM; Yao SY; Ng AM; O'Neill D; Karpinski E; Young JD; Cheeseman CI
    Am J Physiol Renal Physiol; 2012 Aug; 303(4):F527-39. PubMed ID: 22647630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SLC2A9 is a newly identified urate transporter influencing serum urate concentration, urate excretion and gout.
    Vitart V; Rudan I; Hayward C; Gray NK; Floyd J; Palmer CN; Knott SA; Kolcic I; Polasek O; Graessler J; Wilson JF; Marinaki A; Riches PL; Shu X; Janicijevic B; Smolej-Narancic N; Gorgoni B; Morgan J; Campbell S; Biloglav Z; Barac-Lauc L; Pericic M; Klaric IM; Zgaga L; Skaric-Juric T; Wild SH; Richardson WA; Hohenstein P; Kimber CH; Tenesa A; Donnelly LA; Fairbanks LD; Aringer M; McKeigue PM; Ralston SH; Morris AD; Rudan P; Hastie ND; Campbell H; Wright AF
    Nat Genet; 2008 Apr; 40(4):437-42. PubMed ID: 18327257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma urate level is directly regulated by a voltage-driven urate efflux transporter URATv1 (SLC2A9) in humans.
    Anzai N; Ichida K; Jutabha P; Kimura T; Babu E; Jin CJ; Srivastava S; Kitamura K; Hisatome I; Endou H; Sakurai H
    J Biol Chem; 2008 Oct; 283(40):26834-8. PubMed ID: 18701466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional cooperation of URAT1 (SLC22A12) and URATv1 (SLC2A9) in renal reabsorption of urate.
    Nakanishi T; Ohya K; Shimada S; Anzai N; Tamai I
    Nephrol Dial Transplant; 2013 Mar; 28(3):603-11. PubMed ID: 23291366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human sodium phosphate transporter 4 (hNPT4/SLC17A3) as a common renal secretory pathway for drugs and urate.
    Jutabha P; Anzai N; Kitamura K; Taniguchi A; Kaneko S; Yan K; Yamada H; Shimada H; Kimura T; Katada T; Fukutomi T; Tomita K; Urano W; Yamanaka H; Seki G; Fujita T; Moriyama Y; Yamada A; Uchida S; Wempe MF; Endou H; Sakurai H
    J Biol Chem; 2010 Nov; 285(45):35123-32. PubMed ID: 20810651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Solute carrier family 2, member 9 and uric acid homeostasis.
    Cheeseman C
    Curr Opin Nephrol Hypertens; 2009 Sep; 18(5):428-32. PubMed ID: 19593129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complex analysis of urate transporters SLC2A9, SLC22A12 and functional characterization of non-synonymous allelic variants of GLUT9 in the Czech population: no evidence of effect on hyperuricemia and gout.
    Hurba O; Mancikova A; Krylov V; Pavlikova M; Pavelka K; Stibůrková B
    PLoS One; 2014; 9(9):e107902. PubMed ID: 25268603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic and Physiological Effects of Insulin-Like Growth Factor-1 (IGF-1) on Human Urate Homeostasis.
    Mandal AK; Leask MP; Sumpter NA; Choi HK; Merriman TR; Mount DB
    J Am Soc Nephrol; 2023 Mar; 34(3):451-466. PubMed ID: 36735516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A 'complexity' of urate transporters.
    Wright AF; Rudan I; Hastie ND; Campbell H
    Kidney Int; 2010 Sep; 78(5):446-52. PubMed ID: 20613716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Population-specific influence of SLC2A9 genotype on the acute hyperuricaemic response to a fructose load.
    Dalbeth N; House ME; Gamble GD; Horne A; Pool B; Purvis L; Stewart A; Merriman M; Cadzow M; Phipps-Green A; Merriman TR
    Ann Rheum Dis; 2013 Nov; 72(11):1868-73. PubMed ID: 23349133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent advances in renal urate transport: characterization of candidate transporters indicated by genome-wide association studies.
    Anzai N; Jutabha P; Amonpatumrat-Takahashi S; Sakurai H
    Clin Exp Nephrol; 2012 Feb; 16(1):89-95. PubMed ID: 22038265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SGLT2 inhibition and renal urate excretion: role of luminal glucose, GLUT9, and URAT1.
    Novikov A; Fu Y; Huang W; Freeman B; Patel R; van Ginkel C; Koepsell H; Busslinger M; Onishi A; Nespoux J; Vallon V
    Am J Physiol Renal Physiol; 2019 Jan; 316(1):F173-F185. PubMed ID: 30427222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of Key Residues for Urate Specific Transport in Human Glucose Transporter 9 (hSLC2A9).
    Long W; Panigrahi R; Panwar P; Wong K; O Neill D; Chen XZ; Lemieux MJ; Cheeseman CI
    Sci Rep; 2017 Jan; 7():41167. PubMed ID: 28117388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between SLC2A9 transporter gene variants and uric acid phenotypes in African American and white families.
    Rule AD; de Andrade M; Matsumoto M; Mosley TH; Kardia S; Turner ST
    Rheumatology (Oxford); 2011 May; 50(5):871-8. PubMed ID: 21186168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Large-scale whole-exome sequencing association studies identify rare functional variants influencing serum urate levels.
    Tin A; Li Y; Brody JA; Nutile T; Chu AY; Huffman JE; Yang Q; Chen MH; Robinson-Cohen C; Macé A; Liu J; Demirkan A; Sorice R; Sedaghat S; Swen M; Yu B; Ghasemi S; Teumer A; Vollenweider P; Ciullo M; Li M; Uitterlinden AG; Kraaij R; Amin N; van Rooij J; Kutalik Z; Dehghan A; McKnight B; van Duijn CM; Morrison A; Psaty BM; Boerwinkle E; Fox CS; Woodward OM; Köttgen A
    Nat Commun; 2018 Oct; 9(1):4228. PubMed ID: 30315176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Critical Roles of Two Hydrophobic Residues within Human Glucose Transporter 9 (hSLC2A9) in Substrate Selectivity and Urate Transport.
    Long W; Panwar P; Witkowska K; Wong K; O'Neill D; Chen XZ; Lemieux MJ; Cheeseman CI
    J Biol Chem; 2015 Jun; 290(24):15292-303. PubMed ID: 25922070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Morin (3,5,7,2',4'-pentahydroxyflavone) exhibits potent inhibitory actions on urate transport by the human urate anion transporter (hURAT1) expressed in human embryonic kidney cells.
    Yu Z; Fong WP; Cheng CH
    Drug Metab Dispos; 2007 Jun; 35(6):981-6. PubMed ID: 17325024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SLC2A9 (GLUT9) mediates urate reabsorption in the mouse kidney.
    Auberson M; Stadelmann S; Stoudmann C; Seuwen K; Koesters R; Thorens B; Bonny O
    Pflugers Arch; 2018 Dec; 470(12):1739-1751. PubMed ID: 30105595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.